Erdafitinib in Asian Patients with Advanced Solid Tumors: an Open-Label, Single-Arm, Phase IIa Trial
BMC CANCER(2024)
关键词
Cholangiocarcinoma,NSCLC,Erdafitinib,FGFR inhibitor,Asian patients
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BMC CANCER(2024)